CA2884281C - Prebiotic thylakoid composition - Google Patents

Prebiotic thylakoid composition Download PDF

Info

Publication number
CA2884281C
CA2884281C CA2884281A CA2884281A CA2884281C CA 2884281 C CA2884281 C CA 2884281C CA 2884281 A CA2884281 A CA 2884281A CA 2884281 A CA2884281 A CA 2884281A CA 2884281 C CA2884281 C CA 2884281C
Authority
CA
Canada
Prior art keywords
thylakoids
composition according
composition
therapeutic
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2884281A
Other languages
English (en)
French (fr)
Other versions
CA2884281A1 (en
Inventor
Per-Ake Albertsson
Charlotte ERLANSON ALBERTSSON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THYLABISCO AB
Original Assignee
THYLABISCO AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THYLABISCO AB filed Critical THYLABISCO AB
Publication of CA2884281A1 publication Critical patent/CA2884281A1/en
Application granted granted Critical
Publication of CA2884281C publication Critical patent/CA2884281C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/206—Bacterial extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • General Preparation And Processing Of Foods (AREA)
CA2884281A 2012-09-11 2013-09-10 Prebiotic thylakoid composition Active CA2884281C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1251019-4 2012-09-11
SE1251019 2012-09-11
PCT/EP2013/068656 WO2014040962A1 (en) 2012-09-11 2013-09-10 Prebiotic thylakoid composition

Publications (2)

Publication Number Publication Date
CA2884281A1 CA2884281A1 (en) 2014-03-20
CA2884281C true CA2884281C (en) 2021-01-05

Family

ID=49209335

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2884281A Active CA2884281C (en) 2012-09-11 2013-09-10 Prebiotic thylakoid composition

Country Status (13)

Country Link
US (1) US20150209396A1 (https=)
EP (1) EP2895012B1 (https=)
JP (1) JP6475162B2 (https=)
KR (1) KR20150053769A (https=)
CN (1) CN104780783A (https=)
AU (1) AU2013314410B2 (https=)
BR (1) BR112015005355A2 (https=)
CA (1) CA2884281C (https=)
DK (1) DK2895012T3 (https=)
ES (1) ES2656619T3 (https=)
NO (1) NO2895012T3 (https=)
WO (1) WO2014040962A1 (https=)
ZA (1) ZA201502431B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017501158A (ja) * 2013-12-18 2017-01-12 ティラビスコ アーベー 嗜好性食品に対する衝動を減らすためのチラコイドの使用
CN107667173A (zh) 2015-05-06 2018-02-06 斯尼普技术有限公司 改变微生物种群和改善微生物群
JP6551934B2 (ja) * 2015-12-18 2019-07-31 森永乳業株式会社 ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤
JP7244977B2 (ja) * 2016-03-11 2023-03-23 シオノギヘルスケア株式会社 腸内細菌叢調整用組成物
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1056358T3 (da) 1998-02-24 2003-09-22 Arla Foods Amba Anvendelse af D-tagatose som en præbiotisk næringsmiddelkomponent
US20030165557A1 (en) * 2000-09-19 2003-09-04 Sunstar, Inc. Food, medicine and method relating to Bifidobacterium proliferation promoting action, allergy preventive action and human cholesterol lowering action
JP2006025669A (ja) * 2004-07-14 2006-02-02 Kumamotoken Kajitsu Nogyo Kyodo Kumiai Rengokai 飲料の製造法
US7700139B2 (en) * 2004-12-30 2010-04-20 Commonwealth Scientific And Industrial Research Organization Method and means for improving bowel health
US20100047270A1 (en) 2005-06-10 2010-02-25 Albertsson Per-Aake Use of plant cell membrane for the treatment of obesity
JP4819767B2 (ja) * 2006-12-12 2011-11-24 株式会社エス・エフ・シー イグサ青汁
US20080175899A1 (en) * 2007-01-19 2008-07-24 Ross Mairi R Formulation for promoting sinus health in nasal cavities
CN101278752A (zh) * 2008-01-29 2008-10-08 梁季鸿 即食卡尼汀天然果蔬饮料干粉系列配方及生产工艺
US20110182930A1 (en) 2008-07-14 2011-07-28 Thylabisco Ab Large-scale process for the preparation of thylakoids
EP3181134B1 (en) * 2009-06-19 2019-10-30 DuPont Nutrition Biosciences ApS Bifidobacteria for treating diabetes and related conditions
US20140037774A1 (en) * 2011-02-25 2014-02-06 Thylabisco Ab Composition comprising thylakoids for delaying the uptake of molecules

Also Published As

Publication number Publication date
CA2884281A1 (en) 2014-03-20
AU2013314410A1 (en) 2015-04-16
BR112015005355A2 (pt) 2017-08-08
CN104780783A (zh) 2015-07-15
JP6475162B2 (ja) 2019-02-27
EP2895012B1 (en) 2017-10-18
KR20150053769A (ko) 2015-05-18
US20150209396A1 (en) 2015-07-30
EP2895012A1 (en) 2015-07-22
ES2656619T3 (es) 2018-02-27
WO2014040962A1 (en) 2014-03-20
NO2895012T3 (https=) 2018-03-17
JP2015533484A (ja) 2015-11-26
ZA201502431B (en) 2017-11-29
AU2013314410B2 (en) 2017-02-23
DK2895012T3 (en) 2018-01-22

Similar Documents

Publication Publication Date Title
Lim et al. Lactobacillus sakei OK67 ameliorates high-fat diet–induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression
Kerry et al. Benefaction of probiotics for human health: A review
Chiang et al. Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products
Márquez-Aguirre et al. Effects of Agave tequilana fructans with different degree of polymerization profiles on the body weight, blood lipids and count of fecal Lactobacilli/Bifidobacteria in obese mice
Sugiharto Role of nutraceuticals in gut health and growth performance of poultry
Wang et al. Bilberry anthocyanin extracts enhance anti-PD-L1 efficiency by modulating gut microbiota
Önal Darilmaz et al. The effects of inulin as a prebiotic supplement and the synbiotic interactions of probiotics to improve oxalate degrading activity
de Carvalho Marchesin et al. A soy-based probiotic drink modulates the microbiota and reduces body weight gain in diet-induced obese mice
Montelius et al. Feeding spinach thylakoids to rats modulates the gut microbiota, decreases food intake and affects the insulin response
EP2457575B1 (en) New method for obtaining a Lactobacillus reuteri strain useful in medical and veterinary prophylaxis and treatment
CA2884281C (en) Prebiotic thylakoid composition
Elabd et al. Investigating of Moringa oleifera role on gut microbiota composition and inflammation associated with obesity following high fat diet feeding
CN110201003A (zh) 微生物区系的组合物及与其相关的方法
Cheng et al. Lactobacillus casei-fermented blueberry pomace augments sIgA production in high-fat diet mice by improving intestinal microbiota
EP2457576A1 (en) New Lactobacillus reuteri strain useful in medical and veterinary prohylaxis and treatment
Mikelsaar et al. Biodiversity of intestinal lactic acid bacteria in the healthy population
Li et al. Microcapsule of sweet orange essential oil changes gut microbiota in diet-induced obese rats
Xie et al. Effects of Ligustrum robustum on gut microbes and obesity in rats
Ramos-Romero et al. Effects of the combination of ω-3 PUFAs and proanthocyanidins on the gut microbiota of healthy rats
Li et al. Apple polysaccharide could promote the growth of Bifidobacterium longum
Yoshinaga et al. Effects of Undaria pinnatifida (wakame) on the human intestinal environment.
WO2008069102A1 (ja) 炎症性腸疾患予防治療剤
Wu et al. Effects of viable Lacticaseibacillus paracasei K56 and its derived postbiotics on obesity and inflammation induced by a high-fat diet
Kuda et al. Effect of food ingredients on susceptible gut indigenous bacteria
Shweta et al. In vitro studies on anti-inflammatory, antioxidant and antihyperglycemic activities of potential probiotic Pediococcus acidilactici NCDC 252

Legal Events

Date Code Title Description
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240909

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241021

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241021

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250902

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250904